David Noakes | |
---|---|
Born | March 1953 |
Nationality | British |
Occupation(s) | Computer consultant, businessman and politician |
Known for | Founding Immuno Biotech Ltd. to promote the controversial use of GcMAF |
Criminal charges | Money laundering, manufacturing, supplying and selling an unlicensed medicine |
Criminal penalty | 15 months imprisonment |
David Noakes (born March 1953) [1] is a British computer consultant, [2] businessman and politician, who founded Immuno Biotech Ltd. to promote the unproven therapy GcMAF [3] and came last in the 2006 UKIP leadership election. He pleaded guilty to "money laundering and manufacturing, supplying and selling an unlicensed medicine" and was sentenced in November 2018 to 15 months' imprisonment. [4]
Noakes was a computer consultant for a decade. [2] In 2004, he designed an alphabetical keyboard layout. [5] He says he has worked for several Cornish companies, including Holman Brothers, Mount Wellington Tin Mine, and Phillips Frith, and in several countries, [6] including in Brussels and for JPMorgan Chase Bank in New York. [7]
Noakes is CEO and owner of Immuno Biotech Ltd. (trade name First Immune), a Guernsey company that promotes the use of the protein GcMAF, a blood product, as a cure for cancer, autism, HIV, multiple sclerosis, and other diseases, [8] [9] claiming to treat 10,000 patients worldwide [10] with income of £1 million per month. [11] Noakes began promoting GcMAF in 2010, [12] and the company had laboratories in Oxford in 2012. [13] Noakes has been on the board of governors of the National Health Federation (a lobbying group promoting alternative medicine [14] ) since April 2016 [15] and was on the long list for Guernsey Press Ambassador of the Year 2013. [16] Noakes advised cancer patients to not take chemotherapy [17] and promoted the treatment to the Guernsey Chamber of Commerce despite criticism from Cancer Research UK; [18] doctors on Guernsey all declined an invite to a meeting about GcMAF. [19]
In July 2014, NatWest bank closed the company's accounts. [20] In 2015, the UK Medicines and Healthcare products Regulatory Agency (MHRA) took over 10,000 vials of GcMAF during an inspection of the company's unlicensed Milton, Cambridgeshire site and shut down production, [17] after it found that the plasma the GcMAF was derived from was not for human use, and that the production site did not meet good manufacturing practice standards. [10] [21] Noakes' former personal assistant, who worked for him in 2012, said that sometimes Noakes' own blood was used. [11] The company had been supplying GcMAF to around 100 Guernsey residents free of charge until imports were prohibited by the Guernsey Border Agency in February 2015. [22] [10] Noakes' company began supplying an alternative called Goleic in place of GcMAF. [23] Noakes claimed in March 2015 that the UK authorities were harassing him and his family, [24] then was interviewed by the BBC's The One Show in May 2015, but stormed out and threatened to smash the camera. [25] A complaint to the BBC Trust about the interview was dismissed. [26] Later that summer, the Swiss regulator Swissmedic closed the First Immune clinic in Bussigny, [27] after five deaths of patients since it opened in October 2013. [28] Noakes worked with American autism doctor Jeff Bradstreet until the latter committed suicide in June 2015, following a federal government raid of his office in connection to his work on GcMAF. Noakes also worked with scientist Marco Ruggiero until Noakes' Swiss clinic was closed. [29]
In November 2015, Noakes was found guilty by an employment tribunal of sex discrimination against his former personal assistant at Immuno Biotech, Lucia Pagliarone, and was made to pay £10,500. Pagliarone claimed she was asked to give injections as part of her role, despite not having medical training. [30] [31] [32]
Despite a police search of the Immuno Biotech office and a home in January 2016, [33] Noakes had predicted in November 2016 that the MHRA investigation would come to nothing and he would "take down" the regulator; [34] however, Guernsey police again raided the Immuno Biotech office in Lower Pollet in February 2017 [35] and arrested a man and a woman, which Noakes said was a "smear campaign". [36] French gendarmes also raided three Immuno Biotech sites in Normandy in February 2017. [37] [38] Noakes also ran a company, Macro Innovations, that illegally manufactured GcMAF for patient use at a laboratory in Cambridgeshire. [39] Noakes was charged with money laundering, and conspiracy to manufacture a medicinal product without a licence, by the Crown Prosecution Service's Specialist Fraud Division in July 2017. He stood trial at Southwark Crown Court in November 2018, along with Brian Hall, Emma Ward and his former wife Loraine Noakes. [40] [8] [9] Two of his Guernsey staff appeared in court in January 2018, in connection with the inquiry into Noakes' suspected criminal conduct. [41]
Noakes pleaded guilty in UK to "money laundering and manufacturing, supplying and selling an unlicensed medicine" and was sentenced in November 2018 to 15 months' imprisonment. [4] He failed to report to police in December 2019 while on bail and was arrested in May 2020 in Truro. In June 2020, a confiscation order of £1,349,400.48 was made at Southwark Crown Court against Noakes and his company. [42]
In April 2021 Noakes pleaded guilty in France to manufacturing and selling fake medicinal products and cosmetics by Internet and sentenced to 4 years of imprisonment. [43]
Noakes joined UKIP in 2003, [44] and was its parliamentary candidate in Truro and St Austell in 2005, gaining 5.3% of the vote. [45] Noakes came last of the four candidates in the 2006 UKIP leadership election, with 851 votes. During the election campaign he called the EU a "police state" and advocated UKIP forming a shadow cabinet; [2] [46] Nigel Farage won with 3,329 votes. [47] Noakes left UKIP in February 2007, writing in a letter that the leadership had betrayed the membership; Mark Croucher said Noakes was "a swivel-eyed loon whose insane conspiracy theories make the rest of us look as mad as a box of frogs". [44]
Noakes was an independent town councillor for Penwerris ward on Falmouth Town Council and a member of the planning committee from May 2007 until January 2010, when he resigned due to "work commitments". [48] [49] [50] [51] He was fourth on the list for the United Kingdom First Party in the East Midlands region for the 2009 European Parliament elections; [52] UK First received 1.7% of the vote. [53] He stood in the December 2015 Guernsey by-election in Saint Peter Port North [54] on a platform of increased democracy in Guernsey and introducing a constitution, [55] gaining 109 votes (12.3%). [56]
Noakes runs the website EUTruth.org, [2] and since 2007 has published the free monthly newspaper Westminster News in which he promoted a conspiracy theory that Zionists and the German company Siemens control the BBC. He has also promoted conspiracy theories about the Illuminati. [57]
Noakes was born in London, [7] went to Truro School [6] and has lived in Port Pendennis, Falmouth, Cornwall, [58] Guernsey, and Waldershare in Kent, where he was living before being jailed in 2018. [59]
He was married in 1989 [7] to Loraine, with whom he has a son and a daughter. [2] [8] The two separated in 2007, [60] but did not divorce until 2018. [39] Noakes sailed a yacht called Moonlight out of Falmouth between 2005 and 2010, [61] [62] and holds a pilot's licence. [7]
Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. It became an independent subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. Historically, the company is regarded as the world's first biotechnology company.
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the world's largest independent biotechnology companies, Amgen's Thousand Oaks staff in 2022 numbered approximately 5,000 and included hundreds of scientists, making Amgen the largest employer in Ventura County. As of 2022, Amgen has approximately 24,000 staff in total.
Celgene Corporation is a pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid (lenalidomide), which is used in the treatment of multiple myeloma, and also in certain anemias. The company is incorporated in Delaware, headquartered in Summit, New Jersey, and a subsidiary of Bristol Myers Squibb (BMS).
Cornwall Council, known until 2009 as Cornwall County Council, is the unitary authority which governs the district of Cornwall, which covers the majority of the ceremonial county of the same name in the South West of England. The council has had a Conservative Party majority since the 2021 local elections. Its headquarters is Lys Kernow in Truro.
Truro and Falmouth is a constituency in Cornwall represented in the House of Commons of the UK Parliament since 2019 by Cherilyn Mackrory of the Conservative Party. It is on the South West Peninsula of England, bordered by both the Celtic Sea to the northwest and English Channel to the south. The seat was held by fellow Conservative Sarah Newton from its 2010 creation until her retirement from politics in 2019.
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap.
Cornwall is administered as a county of South West England whose politics are influenced by a number of issues that make it distinct from the general political scene in the wider United Kingdom, and the political trends of neighbouring counties. Its position on the geographical periphery of the island of Great Britain is also a factor.
The region of South West England has, since the 2010 general election, 55 parliamentary constituencies which is made up of 15 borough constituencies and 40 county constituencies. At that election the Conservative Party held the largest number of constituencies, with 36. The Liberal Democrats had 15 and Labour had 4. At the 2015 general election the Liberal Democrats lost all of their seats, while the Conservatives gained one seat from Labour, leaving the Conservatives with 51 and Labour with 4. In the 2017 general election, the Conservatives remained, by far, the largest party with 47 seats, though losing three to Labour, who won 7, and one to the Liberal Democrats, who won 1. In the 2019 general election, the Conservatives increased their number of seats to 48 by regaining Stroud from Labour, who held their other six seats, while the Liberal Democrats retained their sole seat in Bath.
Patrick Soon-Shiong is a South African-American transplant surgeon, billionaire businessman, bioscientist, and media proprietor. He is the inventor of the drug Abraxane, which became known for its efficacy against lung, breast, and pancreatic cancer. Soon-Shiong is the founder of NantWorks, a network of healthcare, biotech, and artificial intelligence startups; an adjunct professor of surgery and executive director of the Wireless Health Institute at the University of California, Los Angeles; and a visiting professor at Imperial College London and Dartmouth College. Soon-Shiong has published more than 100 scientific papers and has more than 230 issued patents worldwide on advancements spanning numerous fields in technology and medicine.
ARIAD Pharmaceuticals, Inc. was an American oncology company, now part of Takeda Oncology, which was founded in 1991 by Harvey J. Berger, M.D. and headquartered in Cambridge, Massachusetts. ARIAD engaged in the discovery, development, and commercialization of medicines for cancer patients.
Miracle Mineral Supplement, often referred to as Miracle Mineral Solution, Master Mineral Solution, MMS or the CD protocol, is a branded name for an aqueous solution of chlorine dioxide, an industrial bleaching agent, that has been falsely promoted as a cure for illnesses including HIV, cancer and the common cold. It is made by mixing aqueous sodium chlorite with an acid. This produces chlorine dioxide, a toxic chemical that can cause nausea, vomiting, diarrhea, and life-threatening low blood pressure due to dehydration.
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that: induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.
GcMAF is a protein produced by modification of vitamin D-binding protein.
Nivolumab, sold under the brand name Opdivo, is a medication used to treat a number of types of cancer. This includes melanoma, lung cancer, malignant pleural mesothelioma, renal cell carcinoma, Hodgkin lymphoma, head and neck cancer, urothelial carcinoma, colon cancer, esophageal squamous cell carcinoma, liver cancer, gastric cancer, and esophageal or gastroesophageal junction (GEJ) cancer. It is used by slow injection into a vein.
Seagen Inc. is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. The company, headquartered in Bothell, Washington, is the industry leader in antibody-drug conjugates or ADCs, a technology designed to harness the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells. Antibody-drug conjugates are intended to spare non-targeted cells and thus reduce many of the toxic effects of traditional chemotherapy, while potentially enhancing antitumor activity.
Donald Gary Young was an American businessman specializing in essential oils and alternative medicine. He was the founder and chief executive officer (CEO) of Young Living, a Utah-based multi-level marketing company that sells essential oils and dietary supplements. Early in his career, Young pleaded guilty to the unlicensed practice of medicine, and his company has faced several government investigations.
Henri A. Termeer was a Dutch biotechnology executive and entrepreneur who is considered a pioneer in corporate strategy in the biotechnology industry for his tenure as CEO at Genzyme. Termeer created a business model adopted by many others in the biotech industry by garnering steep prices— mainly from insurers and government payers— for therapies for rare genetic disorders known as orphan diseases that mainly affect children. Genzyme uses biological processes to manufacture drugs that are not easily copied by generic-drug makers. The drugs are also protected by orphan drug acts in various countries which provides extensive protection from competition and ensures coverage by publicly funded insurers. As CEO of Genzyme from 1981 to 2011, he developed corporate strategies for growth including optimizing institutional embeddedness nurturing vast networks of influential groups and clusters: doctors, private equity, patient-groups, insurance, healthcare umbrella organizations, state and local government, and alumni. Termeer was "connected to 311 board members in 17 different organizations across 20 different industries" He has the legacy of being the "longest-serving CEO in the biotechnology industry.
Cancer Breakthroughs 2020, also known as Cancer Moonshot 2020 is a coalition with the goal of finding vaccine-based immunotherapies against cancer. By pooling the resources of multinational pharmaceutical, biotechnology companies, academic centers and oncologists, it intends to create access to over 60 novel and approved agents under exploration in the war against cancer and is expected to enable rapid testing of novel immunotherapy combination protocols. The initiative is being managed by a consortium of companies called The National Immunotherapy Coalition.
The Falmouth Anchor is the online student newspaper of Falmouth University and the University of Exeter's Cornwall campuses.